Literature DB >> 7505074

Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity.

S J McCormack1, L G Ortega, J P Doohan, C E Samuel.   

Abstract

The interferon-induced P1/eIF-2 alpha protein kinase cDNA, designated PKR, was expressed both in Escherichia coli and in transfected monkey COS cells. TrpE-PKR fusion proteins and PKR nonfusion proteins were examined for their RNA-binding activity by Northwestern blot analysis. PKR is a RNA-binding protein that possesses two copies of a highly conserved motif, RI and RII, within the N-terminal region of the protein. Amino acid residues between 11 and 243 of PKR, which includes both copies of the R motif, displayed RNA-binding activity comparable to that of the full-length 551-amino-acid PKR protein. Analysis of substitution and deletion mutant PKR proteins revealed that motif RI was both necessary and sufficient for RNA-binding activity, whereas motif RII was not. Substitution of the highly conserved lysine at position 64 within the RI motif abolished RNA-binding activity, both of full-length PKR and the N-terminal 243-amino-acid truncated PKR. Finally, PKR substitution and deletion mutant cDNAs deficient for kinase function were expressed to much higher levels in transfected monkey cells than was the full-length wild-type PKR cDNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7505074     DOI: 10.1006/viro.1994.1011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR.

Authors:  S Nanduri; F Rahman; B R Williams; J Qin
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

2.  Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR.

Authors:  Y Liu; M Lei; C E Samuel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 3.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

4.  Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR.

Authors:  Sean A McKenna; Darrin A Lindhout; Takashi Shimoike; Colin Echeverría Aitken; Joseph D Puglisi
Journal:  J Mol Biol       Date:  2007-06-15       Impact factor: 5.469

5.  Double-stranded RNA-activated protein kinase (PKR) is negatively regulated by 60S ribosomal subunit protein L18.

Authors:  K U Kumar; S P Srivastava; R J Kaufman
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  PACT, a protein activator of the interferon-induced protein kinase, PKR.

Authors:  R C Patel; G C Sen
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

7.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.

Authors:  M Benkirane; C Neuveut; R F Chun; S M Smith; C E Samuel; A Gatignol; K T Jeang
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

8.  Protein kinase PKR catalytic activity is required for the PKR-dependent activation of mitogen-activated protein kinases and amplification of interferon beta induction following virus infection.

Authors:  Nora Taghavi; Charles E Samuel
Journal:  Virology       Date:  2012-03-03       Impact factor: 3.616

9.  Mechanism of interferon action: characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase.

Authors:  D C Thomis; C E Samuel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  dsRBM1 and a proline-rich domain of RNA helicase A can form a composite binder to recognize a specific dsDNA.

Authors:  Ming-Lung Hung; Ping Chao; Kung-Yao Chang
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.